Key statistics
On Thursday, Clearpoint Neuro Inc (CLPT:NAQ) closed at 11.12, -21.27% below its 52-week high of 14.13, set on Oct 18, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 11.08 |
---|---|
High | 11.19 |
Low | 10.85 |
Bid | 10.90 |
Offer | 12.50 |
Previous close | 10.96 |
Average volume | 288.74k |
---|---|
Shares outstanding | 27.58m |
Free float | 25.42m |
P/E (TTM) | -- |
Market cap | 305.91m USD |
EPS (TTM) | -0.6912 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 20:59 GMT.
More ▼
- ClearPoint Neuro feliciteert partner AviadoBio met de behandeling van de eerste patiënt in klinisch onderzoek ASPIRE-FTD, waarin AVB-101 wordt geëvalueerd voor frontotemporale dementie met GRN-mutaties
- ClearPoint Neuro si congratula con il proprio partner AviadoBio per il primo paziente trattato nello studio clinico ASPIRE-FTD, che valuta la terapia genica sperimentale AVB-101 per la demenza frontotemporale con mutazioni GRN
- ClearPoint Neuro félicite son partenaire AviadoBio pour son premier patient traité dans le cadre de son essai clinique ASPIRE-FTD évaluant l’AVB-101 dans la démence fronto-temporale avec mutations du gène GRN
- ClearPoint Neuro beglückwünscht seinem Partner AviadoBio zur Behandlung des ersten Patienten in der klinischen Studie ASPIRE-FTD, in der AVB-101 für frontotemporale Demenz mit GRN-Mutationen evaluiert wird
- ClearPoint Neuro felicita a su socio AviadoBio por el primer paciente tratado en su ensayo clínico ASPIRE-FTD que evalúa AVB-101 en personas con demencia frontotemporal con mutaciones en el gen GRN
- ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations
- ClearPoint Neuro Announces First EU MDR Certification Success and Approval to Ship Product to Europe
- ClearPoint Neuro gibt erste erfolgreiche EU-MDR-Zertifizierung und Genehmigung zur Lieferung von Produkten nach Europa bekannt
- ClearPoint Neuro annoncerer første EU MDR certificeringssucces og godkendelse til at sende produkt til Europa
- ClearPoint Neuro tillkännager sin första EU MDR-certifiering och godkännande att skicka produkter till Europa
More ▼